v3.26.1
Organization, Business Operations and Liquidity (Details Narrative) - USD ($)
12 Months Ended
Mar. 31, 2026
Dec. 01, 2025
Jun. 30, 2026
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
Goodwill     $ 0
Asset Purchase Agreement [Member]      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
cash transactions $ 1,325,000   1,325,000
deferred purchase price 1,000,000   1,000,000
Services fees expense $ 175,000   $ 175,000
Rorschach Cayman LLC [Member]      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
Ownership percentage   100.00%  
Guidant Bio Therapeutics Inc. [Member] | Asset Purchase Agreement [Member]      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
percentage of common stock interest 40.00%   40.00%